Who owns CareDx, Inc. (CDNA)? Elite investor 13F holders

4 tracked elite investors reported holding CareDx, Inc as of 2026-09-30, including D.E. Shaw, Renaissance Technologies LLC, First Eagle Investment Management, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Health Care Equipment & Services

CareDx, Inc. provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally. The company provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression profiling solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
D.E. ShawCAREDX INCSHARE2026-09-302026-11-16 00:00:0083384405.00 USD1282837.000000SharesaddOriginal filing
Renaissance Technologies LLCCAREDX INCSHARE2026-09-302026-11-12 00:00:0081613870.00 USD1255598.000000SharesaddOriginal filing
First Eagle Investment ManagementCAREDX INCSHARE2026-09-302026-11-10 00:00:0032082830.00 USD493582.000000SharesreduceOriginal filing
Gotham Asset ManagementCAREDX INCSHARE2026-09-302026-11-16 00:00:004377035.00 USD67339.000000SharesreduceOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown